Several studies found that higher SSTR2 expression is strongly associated with non-high-risk and differentiated neuroblastoma, and lack of SSTR expression has been found to correlate with advanced disease and decreased survival [82,90,95,96,97], while others did not find any prognostic relation [37]. This evidence concerns the gene SSTR2 and neuroblastoma.